NCT00093470 2024-03-20
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
National Cancer Institute (NCI)
Phase 3 Completed
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Heart, Lung, and Blood Institute (NHLBI)